Daymark Wealth Partners LLC Has $1.55 Million Stake in Corteva, Inc. $CTVA

Daymark Wealth Partners LLC decreased its holdings in Corteva, Inc. (NYSE:CTVA) by 35.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,054 shares of the company’s stock after selling 12,791 shares during the quarter. Daymark Wealth Partners LLC’s holdings in Corteva were worth $1,545,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of CTVA. E. Ohman J or Asset Management AB increased its stake in shares of Corteva by 13.3% in the fourth quarter. E. Ohman J or Asset Management AB now owns 23,235 shares of the company’s stock valued at $1,557,000 after buying an additional 2,735 shares in the last quarter. Avanza Fonder AB acquired a new position in Corteva during the 4th quarter worth about $752,000. Appleton Partners Inc. MA acquired a new position in Corteva during the 4th quarter worth about $245,000. S.E.E.D. Planning Group LLC grew its holdings in Corteva by 6.9% during the 4th quarter. S.E.E.D. Planning Group LLC now owns 185,508 shares of the company’s stock worth $12,435,000 after acquiring an additional 11,938 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in Corteva by 13.6% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 172,072 shares of the company’s stock worth $12,154,000 after acquiring an additional 20,572 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CTVA shares. Citigroup boosted their target price on shares of Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. BNP Paribas Exane increased their price target on shares of Corteva from $72.00 to $74.00 in a research note on Monday, March 9th. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and boosted their price objective for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Oppenheimer set a $86.00 price objective on Corteva in a report on Thursday, February 5th. Finally, Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 20th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $82.90.

Corteva Stock Performance

Corteva stock opened at $82.00 on Thursday. The company has a market cap of $55.05 billion, a PE ratio of 51.90, a PEG ratio of 2.75 and a beta of 0.72. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $82.26. The company’s 50-day moving average is $75.76 and its two-hundred day moving average is $69.53.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter in the previous year, the company earned $0.32 EPS. Corteva’s revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were given a dividend of $0.18 per share. The ex-dividend date was Monday, March 2nd. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is presently 45.57%.

Insider Activity at Corteva

In other news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.14% of the company’s stock.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.